UPB insider trading
NasdaqGS HealthcareUpstream Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Upstream Bio, Inc.
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Company website: upstreambio.com
UPB insider activity at a glance
FilingIQ has scored 27 insider transactions for UPB since Oct 15, 2024. The most recent filing in our index is dated Mar 16, 2026.
Across the full history, 5 open-market purchases
and 5 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on UPB insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest UPB Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading UPB
Frequently asked
- How many insider trades does FilingIQ track for UPB?
- FilingIQ tracks 27 Form 4 insider transactions for UPB (Upstream Bio, Inc.), covering filings from Oct 15, 2024 onwards. 5 of those were filed in the last 90 days.
- Are UPB insiders net buyers or net sellers?
- Across the full Form 4 history for UPB, 5 transactions (19%) were open-market purchases and 5 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does UPB insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is UPB in?
- Upstream Bio, Inc. (UPB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $524.71M.
Methodology & sources
Every UPB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.